title: Preclinical study of a recombinant soluble tumor necrosis factor receptor: effect on immune response of renal allograft recipients.
authors.affiliation: Transplantation Unit, Massachusetts General Hospital, Boston.
authors.forename: S
authors.initials: S
authors.lastname: Wee
authors.forename: S
authors.initials: S
authors.lastname: Boskovic
authors.forename: J D
authors.initials: JD
authors.lastname: Eason
authors.forename: M B
authors.initials: MB
authors.lastname: Widmer
authors.forename: A
authors.initials: A
authors.lastname: Benedict Cosimi
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008252:Macaca fascicularis; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D016572:Cyclosporine